PA
MIRM icon

Profund Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Profund Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Sell
15,263
-6,920
-31% -$695K 0.05% 223
2026
Q1 		$2.05M Sell
22,183
-4,908
-18% -$462K 0.08% 197
2025
Q4 		$2.14M Buy
27,091
+19,515
+258% +$1.4M 0.07% 202
2025
Q3 		$555K Sell
7,576
-611
-7% -$38.8K 0.02% 478
2025
Q2 		$417K Sell
8,187
-2,815
-26% -$125K 0.02% 529
2025
Q1 		$496K Buy
11,002
+1,820
+20% +$85.8K 0.02% 476
2024
Q4 		$380K Sell
9,182
-7,802
-46% -$325K 0.01% 655
2024
Q3 		$662K Buy
16,984
+3,976
+31% +$159K 0.03% 425
2024
Q2 		$445K Sell
13,008
-27,856
-68% -$730K 0.02% 540
2024
Q1 		$1.03M Buy
40,864
+19,694
+93% +$541K 0.04% 355
2023
Q4 		$625K Sell
21,170
-1,886
-8% -$57.1K 0.03% 447
2023
Q3 		$729K Buy
23,056
+1,940
+9% +$53.1K 0.04% 361
2023
Q2 		$546K Buy
21,116
+5,107
+32% +$136K 0.03% 488
2023
Q1 		$385K Buy
+16,009
New +$365K 0.02% 609

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Profund Advisors's MIRM Position: Q2 2026 in Review

Profund Advisors reduced its Mirum Pharmaceuticals (MIRM) stake by 31% in Q2 2026, selling an estimated $695K and leaving 15,263 shares worth $1.79M. The position accounts for 0.05% of the portfolio, ranked #223.

Profund Advisors first reported a position in MIRM in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.14M in Q4 2025. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Profund Advisors held 15,263 shares of Mirum Pharmaceuticals worth $1.79M as of Q2 2026.
  • Profund Advisors sold 6,920 Mirum Pharmaceuticals shares in Q2 2026, an estimated $695K.
  • Mirum Pharmaceuticals made up 0.05% of Profund Advisors's portfolio in Q2 2026, its #223 holding.
  • Profund Advisors first reported a position in Mirum Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Profund Advisors's Mirum Pharmaceuticals position peaked at $2.14M in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.